The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement
Abstract
DESCRIPTION: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis. METHODS: The USPSTF evaluated evidence on the diagnostic accuracy of risk assessment instruments for osteoporosis and fractures, the performance of dual-energy x-ray absorptiometry and peripheral bone measurement tests in predicting fractures, the harms of screening for osteoporosis, and the benefits and harms of drug therapy for osteoporosis in women and men. RECOMMENDATIONS: The USPSTF recommends screening for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis in men. (I statement).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, DXA is routinely performed for screening and assessment of osteoporosis and is generally covered by insurance for this indication341.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [341]
Citations
Cites
Cummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277 · cited 2×
“In the largest trial of bisphosphonates, the Fracture Intervention Trial of alendronate, fractures were significantly reduced only in women with baseline femoral neck T-scores less than 2.5 (1).”
InfluentialKanis, J. A., Oden, A., Johnell, O., Johansson, H., De Laet, C., Brown, J., Burckhardt, P., Cooper, C., Christiansen, C., Cummings, S., et al. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0343-y · Cited by 1,224 · cited 2×
“For each SD reduction in BMD at the femoral neck, the hazard ratio for vertebral and nonvertebral fractures increased to a similar degree in both men and women (6, 7).”
Orwoll, E., Scheele, W., Paul, S., Adami, S., Syversen, U., Diez-Perez, A., Kaufman, J.-M., Clancy, A., & Gaich, G. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.9 · Cited by 776 · cited 1×
“A single primary prevention trial of parathyroid hormone reported a non–statistically significant trend toward a reduction in vertebral and nonvertebral fractures (11).”
Screening for Osteoporosis: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Haney, E. M., Dana, T., Bougatsos, C., & Chou, R. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-2-201007200-00262 · Cited by 216 · cited 5×
“The evidence is strongest and most consistent for bisphosphonates and raloxifene (2).”
InfluentialUse of Alendronate and Risk of Incident Atrial Fibrillation in Women
Heckbert, S. R., Li, G., Cummings, S. R., Smith, N. L., & Psaty, B. M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.826 · Cited by 199 · cited 1×
“15]) (12), but a smaller case–control study in Washington showed no increased risk for atrial fibrillation with any use of etidronate (RR, 0.”
Sørensen, H. T., Christensen, S., Mehnert, F., Pedersen, L., Chapurlat, R. D., Cummings, S. R., & Baron, J. A. (2008) · BMJ · doi:10.1136/bmj.39507.551644.be · Cited by 178 · cited 1×
“21]) (13) compared with no use of either agent.”
Qaseem, A., Snow, V., Shekelle, P., Hopkins, R., Forciea, M. A., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00008 · Cited by 168
Meta-Analysis: Accuracy of Quantitative Ultrasound for Identifying Patients with Osteoporosis
Nayak, S., Olkin, I., Liu, H., Grabe, M., Gould, M. K., Allen, I. E., Owens, D. K., & Bravata, D. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-11-200606060-00009 · Cited by 149
Hillier, T. A., Stone, K. L., Bauer, D. C., Rizzo, J. H., Pedula, K. L., Cauley, J. A., Ensrud, K. E., Hochberg, M. C., & Cummings, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.2.155 · Cited by 142 · cited 1×
“A prospective study of 4124 women aged 65 years or older found that neither repeated BMD measurement nor the change in BMD after 8 years was more predictive of subsequent fracture risk than the original measurement (4).”
Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Nelson, H. D., Fu, R., Griffin, J. C., Nygren, P., Smith, M. E. B., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0000605-200911170-00147 · Cited by 102
Cited by
Winstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., Deruyter, F., Eng, J. J., Fisher, B., Harvey, R. L., et al. (2016) · Stroke · doi:10.1161/str.0000000000000098 · Cited by 3,293
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Miller, P. D., Hattersley, G., Riis, B. J., Williams, G. C., Lau, E., Russo, L. A., Alexandersen, P., Zerbini, C. A. F., Hu, M.-Y., Harris, A. G., et al. (2016) · JAMA · doi:10.1001/jama.2016.11136 · Cited by 875
Ensrud, K. E., & Crandall, C. J. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201708010 · Cited by 726
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
Metadata
- Authors
- U.S. Preventive Services Task Force*
- Corresponding author
- U.S. Preventive Services Task Force*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2011-03-01
- Volume
- 154
- Issue
- 5
- Pages
- 356-364
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2412606294
- Cited by
- 436
- References
- 11
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 14 · 2023: 11 · 2022: 15 · 2021: 18 · 2020: 26 · 2019: 21 · 2018: 44 · 2017: 41 · 2016: 42 · 2015: 40 · 2014: 38 · 2013: 41 · 2012: 39
- FWCI
- 48.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- osteoporosis screening, fracture risk assessment, dual-energy X-ray absorptiometry, osteoporosis drug therapy, fracture risk prediction, diagnostic accuracy, screening harms, men
- MeSH terms
- Aged, Calcaneus, Costs and Cost Analysis, Female, Humans, Male, Mass Screening, Middle Aged, Osteoporosis, Ultrasonography, Absorptiometry, Photon, Bone Density, Cost of Illness, Risk Assessment, Osteoporotic Fractures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement. https://app.cochat.ai/papers/10.7326/0003-4819-154-5-201103010-00307
- The paper
- U.S. Preventive Services Task Force*. (2011). Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-154-5-201103010-00307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.